Physician profile
Sabri Sellaouti
NPI 1528642634
$5,789.90
in general payments reported to CMS, 2019-2025
9 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,254 · 2024: $2,046 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,350 · Food and Beverage: $2,240 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,350.10 |
| Food and Beverage | $2,239.80 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,997.71 | 2023-2024 | Da Vinci Surgical System, Da Vinci Sp, Davinci Xi |
| Solventum Corporation | $1,461.50 | 2024 | Prevena, Abthera, V.A.C. Veraflo |
| Baxter Healthcare | $905.80 | 2023-2025 | Perclot, Tisseel, Peri-Strips Dry |
| Ethicon US, LLC | $220.49 | 2024-2025 | Linx Reflux Management System, Echelon Flex |
| Medical Device Business Services, INC. | $71.06 | 2024 | Vistaseal |
| Kci USA, INC. | $49.13 | 2023 | V.A.C. Veraflo, Abthera, Prevena |
| Conmed Corporation | $46.88 | 2025 | Airseal |
| Medtronic, INC. | $20.44 | 2025 | Pteye Parathyroid Detection System |
| Davol INC. | $16.89 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabri Sellaouti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.